{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:09:46Z","timestamp":1767373786461,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI08\/1770","PI08\/0533","PI08\/1359","PI09\/00773","PI09\/01286","PI09\/01903","PI09\/02078","PI09\/01662","PI11\/01403","PI11\/01889","PI11\/00226","PI11\/01810","PI11\/02213","PI12\/00488","PI12\/00265","PI12\/01270","PI12\/00715","PI12\/00150","PI14\/01219"],"award-info":[{"award-number":["PI08\/1770","PI08\/0533","PI08\/1359","PI09\/00773","PI09\/01286","PI09\/01903","PI09\/02078","PI09\/01662","PI11\/01403","PI11\/01889","PI11\/00226","PI11\/01810","PI11\/02213","PI12\/00488","PI12\/00265","PI12\/01270","PI12\/00715","PI12\/00150","PI14\/01219"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2692-4","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T01:13:07Z","timestamp":1471655587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study"],"prefix":"10.1186","volume":"16","author":[{"given":"Trinidad","family":"Dierssen-Sotos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"G\u00f3mez-Acebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"de Pedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"P\u00e9rez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Servitja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Amiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Fernandez-Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Barricarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adonina","family":"Tardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Diaz-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana","family":"Peiro-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Marcos-Gragera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Lope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Gracia-Lavedan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Henar","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jesus","family":"Michelena-Echeveste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Garcia-Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Casta\u00f1o-Vinyals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Aragon\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manolis","family":"Kogevinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Poll\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,20]]},"reference":[{"issue":"55","key":"2692_CR1","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1038\/sj.onc.1203286","volume":"18","author":"CS Williams","year":"1999","unstructured":"Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999;18(55):7908\u201316.","journal-title":"Oncogene"},{"issue":"8","key":"2692_CR2","first-page":"2101","volume":"20","author":"RE Harris","year":"2000","unstructured":"Harris RE, Alshafie GA, Seibert K. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res. 2000;20(8):2101\u20133.","journal-title":"Cancer Res"},{"issue":"1","key":"2692_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/bjoc.2000.1119","volume":"83","author":"CR Sharpe","year":"2000","unstructured":"Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer. 2000;83(1):112\u201320.","journal-title":"Br J Cancer"},{"issue":"18","key":"2692_CR4","first-page":"6096","volume":"63","author":"RE Harris","year":"2003","unstructured":"Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A. Women\u2019s Health Initiative. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women\u2019s Health Initiative. Cancer Res. 2003;63(18):6096\u2013101.","journal-title":"Cancer Res"},{"issue":"11","key":"2692_CR5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst. 2005;97(11):805\u201312.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2692_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/pmed.1995.1018","volume":"24","author":"L Rosenberg","year":"1995","unstructured":"Rosenberg L. Nonsteroidal anti-inflammatory drugs and cancer. Prev Med. 1995;24(2):107\u20139.","journal-title":"Prev Med"},{"issue":"2","key":"2692_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/pmed.1999.0518","volume":"29","author":"PF Coogan","year":"1999","unstructured":"Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S. The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med. 1999;29(2):72\u20136.","journal-title":"Prev Med"},{"key":"2692_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2407-5-159","volume":"5","author":"E Rahme","year":"2005","unstructured":"Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M. Association between frequent use of nonsteroidal antiinflammatory drugs and breast cancer. BMC Cancer. 2005;5:159.","journal-title":"BMC Cancer"},{"key":"2692_CR9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10549-015-3267-9","volume":"149","author":"M Pedro de","year":"2015","unstructured":"de Pedro M, Baeza S, Escudero MT, Dierssen-Sotos T, Gomez-Acebo I, Pollan M, Llorca J. Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2015;149:525\u201336.","journal-title":"Breast Cancer Res Treat"},{"key":"2692_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-6-27","volume":"6","author":"RE Harris","year":"2006","unstructured":"Harris RE, Beebe-Donk J, Alshafie GA. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer. 2006;6:27.","journal-title":"BMC Cancer"},{"issue":"1","key":"2692_CR11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.breast.2010.07.004","volume":"20","author":"V Ashok","year":"2011","unstructured":"Ashok V, Dash C, Rohan TE, Sprafka JM, Terry PD. Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk. Breast. 2011;20(1):66\u201370.","journal-title":"Breast"},{"issue":"3","key":"2692_CR12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bjc.2011.252","volume":"105","author":"Y Vinogradova","year":"2011","unstructured":"Vinogradova Y, Coupland C, Hippisley-Cox J. Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies. Br J Cancer. 2011;105(3):452\u20139.","journal-title":"Br J Cancer"},{"issue":"4","key":"2692_CR13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.gaceta.2014.12.003","volume":"29","author":"G Casta\u00f1o-Vinyals","year":"2015","unstructured":"Casta\u00f1o-Vinyals G, et al. Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. Gac Sanit. 2015;29(4):308\u201315.","journal-title":"Gac Sanit"},{"key":"2692_CR14","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. 2015. http:\/\/www.whocc.no\/atc_ddd_index\/ . Accessed: 5 May, 2015."},{"key":"2692_CR15","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci U S A. 1999;96:7563\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2692_CR16","first-page":"591","volume":"2","author":"R Harris","year":"1995","unstructured":"Harris R, Namboodiri K, Farrar W. Epidemiologic-study of nonsteroidal antiinflammatory drugs and breast-cancer. Oncol Rep. 1995;2(4):591\u20132.","journal-title":"Oncol Rep"},{"issue":"2","key":"2692_CR17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","volume":"7","author":"RE Harris","year":"1996","unstructured":"Harris RE, Namboodiri KK, Farrar WB. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology. 1996;7(2):203\u20135.","journal-title":"Epidemiology"},{"issue":"11","key":"2692_CR18","first-page":"1213","volume":"10","author":"M Cotterchio","year":"2001","unstructured":"Cotterchio M, Kreiger N, Sloan M, Steingart A. Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10(11):1213\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"2692_CR19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1023\/B:CACO.0000007973.59863.66","volume":"14","author":"PG Moorman","year":"2003","unstructured":"Moorman PG, Grubber JM, Millikan RC, Newman B. Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control. 2003;14(10):915\u201322.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2692_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000084818","volume":"68","author":"H Swede","year":"2005","unstructured":"Swede H, Mirand AL, Menezes RJ, Moysich KB. Association of regular aspirin use and breast cancer risk. Oncology. 2005;68(1):40\u20137.","journal-title":"Oncology"},{"issue":"6","key":"2692_CR21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/aje\/kwm216","volume":"166","author":"VA Kirsh","year":"2007","unstructured":"Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B. Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Am J Epidemiol. 2007;166(6):709\u201316.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2692_CR22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ki.2013.79","volume":"84","author":"SM Ou","year":"2013","unstructured":"Ou SM, Chen YT, Chao PW, Lee YJ, Liu CJ, Yeh CM, Chen TJ, Chen TW, Yang WC, Li SY. Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients. Kidney Int. 2013;84(1):198\u2013205.","journal-title":"Kidney Int"},{"issue":"2","key":"2692_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/pmed.1995.1022","volume":"24","author":"RE Harris","year":"1995","unstructured":"Harris RE, Namboodiri K, Stellman SD, Wynder EL. Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev Med. 1995;24(2):119\u201320.","journal-title":"Prev Med"},{"issue":"7250","key":"2692_CR24","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","volume":"320","author":"MJ Langman","year":"2000","unstructured":"Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ. 2000;320(7250):1642\u20136.","journal-title":"BMJ"},{"issue":"3","key":"2692_CR25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1592\/phco.22.5.303.33189","volume":"22","author":"CR Meier","year":"2002","unstructured":"Meier CR, Schmitz S, Jick H. Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy. 2002;22(3):303\u20139.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"2692_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/aje\/kwi182","volume":"162","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-control Surveillance Study revisited. Am J Epidemiol. 2005;162(2):165\u201370.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2692_CR27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-007-9135-0","volume":"22","author":"S Davis","year":"2007","unstructured":"Davis S, Mirick DK. Medication use and the risk of breast cancer. Eur J Epidemiol. 2007;22(5):319\u201325.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"2692_CR28","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr2482","volume":"12","author":"DP Cronin-Fenton","year":"2010","unstructured":"Cronin-Fenton DP, Pedersen L, Lash TL, Friis S, Baron JA, S\u00f8rensen HT. Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study. Breast Cancer Res. 2010;12(2):R15.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2692_CR29","first-page":"71","volume":"6","author":"RE Harris","year":"1999","unstructured":"Harris RE, Kasbari S, Farrar WB. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep. 1999;6(1):71\u20133.","journal-title":"Oncol Rep"},{"issue":"12","key":"2692_CR30","first-page":"1586","volume":"11","author":"TW Johnson","year":"2002","unstructured":"Johnson TW, Anderson KE, Lazovich D, Folsom AR. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1586\u201391.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2692_CR31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.22656","volume":"121","author":"L Gallicchio","year":"2007","unstructured":"Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ. Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD. Int J Cancer. 2007;121(1):211\u20135.","journal-title":"Int J Cancer"},{"issue":"10","key":"2692_CR32","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/aje\/kwm195","volume":"166","author":"JK Gill","year":"2007","unstructured":"Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN. Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol. 2007;166(10):1150\u20138.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2692_CR33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10549-007-9665-x","volume":"109","author":"A Ready","year":"2008","unstructured":"Ready A, Velicer CM, McTiernan A, White E. NSAID use and breast cancer risk in the VITAL cohort. Breast Cancer Res Treat. 2008;109(3):533\u201343.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2692_CR34","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/bcr2089","volume":"10","author":"GL Gierach","year":"2008","unstructured":"Gierach GL, Lacey Jr JV, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res. 2008;10(2):R38.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"2692_CR35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/156800908786733414","volume":"8","author":"C Siemes","year":"2008","unstructured":"Siemes C, Visser LE, Coebergh JW, Hofman A, Uitterlinden AG, Stricker BH. Protective effect of NSAIDs on cancer and influence of COX-2 C(\u2212765G) genotype. Curr Cancer Drug Targets. 2008;8(8):753\u201364.","journal-title":"Curr Cancer Drug Targets"},{"issue":"11","key":"2692_CR36","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.bjc.6600945","volume":"88","author":"HT S\u00f8rensen","year":"2003","unstructured":"S\u00f8rensen HT, Friis S, N\u00f8rg\u00e5rd B, Mellemkjaer L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer. 2003;88(11):1687\u201392.","journal-title":"Br J Cancer"},{"issue":"1","key":"2692_CR37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1055-9965.261.14.1","volume":"14","author":"EJ Jacobs","year":"2005","unstructured":"Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large US cohort. Cancer Epidemiol Biomarkers Prev. 2005;14(1):261\u20134.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2692_CR38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/CEJ.0b013e3282b6fd55","volume":"17","author":"S Friis","year":"2008","unstructured":"Friis S, Thomassen L, S\u00f8rensen HT, Tj\u00f8nneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Eur J Cancer Prev. 2008;17(2):88\u201396.","journal-title":"Eur J Cancer Prev"},{"key":"2692_CR39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000071377","volume":"37","author":"JW Soh","year":"2003","unstructured":"Soh JW, Weinstein IB. Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. Prog Exp Tumor Res. 2003;37:261\u201385.","journal-title":"Prog Exp Tumor Res"},{"key":"2692_CR40","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djj206","volume":"98","author":"S Grosch","year":"2006","unstructured":"Grosch S, Maier TJ, Schiffmann S, Geisslinger G. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst. 2006;98:736\u201347.","journal-title":"J Natl Cancer Inst"},{"key":"2692_CR41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5306\/wjco.v5.i4.677","volume":"5","author":"RE Harris","year":"2014","unstructured":"Harris RE, Casto BC, Harris ZM. Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol. 2014;5:677\u201392.","journal-title":"World J Clin Oncol"},{"key":"2692_CR42","unstructured":"Hartmann LC, Lingle W, Frost MH, Shaun D, Maloney RA, Vierkant V, Pankratz S, Tisty T, Degnim AC, Visscher DW. COX-2 expression in atypia: correlation with breast cancer risk.\u00a097th Annual Meeting.\u00a0Proc Amer Assoc Cancer Res. 2006; 47: Abstract No. 2353"},{"key":"2692_CR43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/erc.0.0080097","volume":"8","author":"LR Howe","year":"2001","unstructured":"Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer. 2001;8:97\u2013114.","journal-title":"Endocr Relat Cancer"},{"key":"2692_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.prostaglandins.2006.07.003","volume":"81","author":"JR Prosperi","year":"2006","unstructured":"Prosperi JR, Robertson FM. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells. Prostaglandins Other Lipid Mediat. 2006;81:55\u201370.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2692_CR45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.57.3.6","volume":"57","author":"SE Bulun","year":"2005","unstructured":"Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005;57:359\u201383.","journal-title":"Pharmacol Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2692-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T19:36:27Z","timestamp":1657136187000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2692-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,20]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2692"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2692-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2016,8,20]]},"article-number":"660"}}